Prof. Taxis partner in European Happy Patient project
Prof. Katja Taxis of the Groningen Research Institute of Pharmacy ( GRIP ) is partner in the EU Happy Patient project aimed at researching doctor-patient strategies to reduce inappropriate antibiotic consumption. The 3-year project’s consortium consists of 16 scientific, university and clinical organizations. They will generate studies, research and training materials in order to prevent the incorrect and excessive prescription of antibiotics at various levels of care.
Professionals and patients will be the targeted audience for interventions and for monitoring the effects before and after the intervention. Family doctors, nurses, dentists and pharmacists working in general practice, out of hours services, nursing homes and community pharmacies will participate. The five target countries for the project are Spain, France, Poland and Greece that hold the highest positions in the European antibiotic consumption statistics, and Lithuania, whose consumption data is at the lowest part of the scope.
Prof. Taxis' project has been awarded EUR 171,000 for her part of the project. She will focus on the adaptation of EU Guidelines for pharmacies in the target countries.
Europe and Antibiotics
The current misuse of antibiotics in many European countries is one of the biggest threats to western societies. The World Health Organization (WHO) Europe Region has been warning for years of the rise of antimicrobial resistance, and the COVID-19 pandemic has not changed its position. According to the available data provided by the European Centre for Disease Prevention and Control, (ECDC) up to 33,000 people die every year in Europe as a direct consequence of the misuse of antibiotics.

Last modified: | 25 January 2021 12.58 p.m. |
More news
-
25 April 2025
Leading microbiologist Arnold Driessen honoured
On 25 April 2025, Arnold Driessen (Horst, the Netherlands, 1958) received a Royal Decoration. Driessen is Professor of Molecular Microbiology and chair of the Molecular Microbiology research department of the Faculty of Science and Engineering at the...
-
24 April 2025
Highlighted papers April 2025
The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.
-
22 April 2025
Microplastics and their effects on the human body
Professor of Respiratory Immunology Barbro Melgert has discovered how microplastics affect the lungs and can explain how to reduce our exposure.